JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1990; 15:1095-1101
© 1990 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farge, D
Right arrow Articles by Carpentier, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farge, D
Right arrow Articles by Carpentier, A

Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients

D Farge, J Julien, C Amrein, R Guillemain, C Vulser, S Mihaileanu, G Dreyfus, and A Carpentier

Service de Chirurgie Cardio-vasculaire, Hopital Broussais, Paris, France.

To evaluate the incidence, risk factors and effects of systemic hypertension on renal function and left ventricular hypertrophy after cardiac transplantation, 85 transplant recipients on triple drug, low dosage, immunosuppressive therapy were studied. After a mean follow-up period of 12.5 +/- 8.7 months, a high incidence of hypertension was observed in 57 (67%) of the patients, and 42 (71%) of the 57 had developed new hypertension. None of the pretransplant and posttransplant cardiovascular risk factors were significantly associated with posttransplant hypertension. Faster deterioration of renal function, as assessed by intraindividual variations of serum creatinine values, was demonstrated in hypertensive patients and appeared as an early indicator of cyclosporine nephrotoxicity in patients at risk for hypertension. Serial echocardiographic evaluations demonstrated an early increase in left ventricular mass and fractional shortening in both hypertensive and normotensive heart transplant recipients. Fractional shortening further diminished significantly in normotensive patients but remained elevated in hypertensive patients, demonstrating sustained enhanced contractility in this group. Further studies will help to determine the exact relation between cyclosporine dosages and hypertension and their respective roles in the development of renal insufficiency and left ventricular hypertrophy after cardiac transplantation.


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
W. Zhang
Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy
Cardiovasc Res, February 1, 2002; 53(2): 294 - 303.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
W. Zhang, R. C. Kowal, F. Rusnak, R. A. Sikkink, E. N. Olson, and R. G. Victor
Failure of Calcineurin Inhibitors to Prevent Pressure-Overload Left Ventricular Hypertrophy in Rats
Circ. Res., April 2, 1999; 84(6): 722 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
L. Gullestad, G. Haywood, H. Aass, H. Ross, G. Yee, T. Ueland, O. Geiran, J. Kjekshus, S. Simonsen, N. Bishopric, et al.
Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation
Cardiovasc Res, May 1, 1998; 38(2): 340 - 347.
[Abstract] [Full Text] [PDF]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1990 by the American College of Cardiology Foundation.